noom glp-1 Why We Launched GLP-1RX Noom Unveils Microdose GLP-1 Program

GLP-1RA intervention was associated with a reduction in LDL when compared to those given metformin or placebo (MD = 0.01

Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial

The detail is contained within two recent publications in prestigious, peer-reviewed medical journals: Doctors at the University of North Carolina in America conducted a small clinical trial of GLP-1 in pouchees who had a high frequency of bowel movements but with a normal pouch (i.e., no inflammation)

Weight change for pediatric completers in a national weight loss program

The protective role on fibrosis progression demonstrated by GLP-1 RAs could be explained by the effect in reducing the expression of three out of five collagen genes [99]